Tandem Diabetes Care (TNDM) Profit After Tax (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Profit After Tax data on file, last reported at -$20.9 million in Q1 2026.

• Quarterly Profit After Tax rose 83.71% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$91.4 million (up 49.72% YoY) and the FY2025 annual result came in at -$204.7 million, down 106.07% from the prior year.
• Profit After Tax slipped to -$20.9 million in Q1 2026, from -$589000.0 in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $755000.0 in Q4 2024 to a low of -$128.5 million in Q1 2025.
• A 5-year average of -$37.5 million and a median of -$30.0 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax tumbled 945.18% — and 2024, when it surged 102.52%.
• Tracing TNDM's Profit After Tax over 5 years: stood at -$15.9 million in 2022, then slumped by 89.26% to -$30.0 million in 2023, then soared by 102.52% to $755000.0 in 2024, then sank by 178.01% to -$589000.0 in 2025, then tumbled by 3455.52% to -$20.9 million in 2026.
• The last three Profit After Tax figures came in at -$20.9 million (Q1 2026), -$589000.0 (Q4 2025), and -$21.2 million (Q3 2025), per Business Quant data.